C’elle menstrual stem cells will be used in preclinical models of CNS disorders.
Cryo-Cell inked an R&D agreement with Saneron CCEL Therapeutics to develop regenerative therapies using Cryo-Cell’s C’elle menstrual stem cell technology. The partners will work on preclinical models for particular neurological diseases.
Cryo-Cell will provide C’elle menstrual stem cells along with associated techniques. Saneron will contribute study materials and research methodology for potential therapeutic applications. The companies will jointly own any intellectual property resulting from this research.
